Vijaya Diagnostic Centre Ltd (VIJAYA) Q3FY26 Concall Summary - Dec-2025 Qtr
Performance Overview
- The company achieved its highest-ever quarterly revenue of INR 205 crores, marking a significant milestone.
- Robust top-line growth of 21.4% year-over-year was driven by a strong volume increase of nearly 15%, indicating healthy demand and successful market penetration.
- The integrated business model demonstrated resilience with balanced growth across both radiology and pathology segments, underscoring the effectiveness of its comprehensive service offering.
- Strategic network expansion continued with the commissioning of four new hubs, reinforcing the company's commitment to making quality diagnostics more accessible in both core and new markets.
- Newly launched hubs in West Bengal achieved break-even in just three quarters, significantly ahead of the guided one-year timeline, highlighting strong brand reception and operational efficiency in new geographies.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.